Skip to main content
Top
Published in: Documenta Ophthalmologica 1/2011

01-08-2011 | Case Report

Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction

Authors: Anastasios Anastasakis, Andrew D. Dick, Erika M. Damato, Paul G. Spry, Mohamed A. Majid

Published in: Documenta Ophthalmologica | Issue 1/2011

Login to get access

Abstract

A 62-year-old female patient presented to our clinic complaining of a 2 month history of shimmering photopsias and floaters. An ocular examination, fluorescein angiography, and electrophysiological testing were obtained that suggested either an inflammatory retinal vasculitis or a paraneoplastic syndrome. Melanoma-associated retinopathy was highly suspected despite the absence of previous history for cutaneous melanoma since an electronegative scotopic ERG was recorded on standard flash electroretinography. Additional investigations revealed the presence of a primary breast tumor with secondary lung and pancreatic metastasis that led to the diagnosis of cancer-associated retinopathy. The patient received chemotherapy and 4 months after the initial presentation her visual complaints but also her retinal function showed marked improvement. Cancer-associated retinopathy needs to be considered in patients presenting with retinal vasculitis and electrophysiological testing can tailor the approach in these cases.
Literature
1.
go back to reference Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606–613PubMed Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF (1976) Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 81:606–613PubMed
2.
go back to reference Khan N, Huang JJ, Foster CS (2006) Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol 21:135–141PubMedCrossRef Khan N, Huang JJ, Foster CS (2006) Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin Ophthalmol 21:135–141PubMedCrossRef
3.
go back to reference Maeda T, Maeda A, Maruyama I, Ogawa K, Kuroki Y, Sahara H, Sato N, Ohguro H (2001) Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 42(3):705–712PubMed Maeda T, Maeda A, Maruyama I, Ogawa K, Kuroki Y, Sahara H, Sato N, Ohguro H (2001) Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 42(3):705–712PubMed
4.
go back to reference Robertson DM (2002) Non-cancerous ophthalmic clues to non-ocular cancer. Surv Ophthalmol 47(5):397–430PubMedCrossRef Robertson DM (2002) Non-cancerous ophthalmic clues to non-ocular cancer. Surv Ophthalmol 47(5):397–430PubMedCrossRef
5.
go back to reference Matsui Y, Mehta MC, Katsumi O, Brodie SE, Hirose T (1992) Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol 230:324–328PubMedCrossRef Matsui Y, Mehta MC, Katsumi O, Brodie SE, Hirose T (1992) Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol 230:324–328PubMedCrossRef
6.
go back to reference Audo I, Robson AG, Holder GE, Moore AT (2008) The negative ERG: clinical phenotypes and disease. Mechanisms of inner retinal dysfunction. Surv Ophthalmol 53:16–40PubMedCrossRef Audo I, Robson AG, Holder GE, Moore AT (2008) The negative ERG: clinical phenotypes and disease. Mechanisms of inner retinal dysfunction. Surv Ophthalmol 53:16–40PubMedCrossRef
7.
go back to reference Koh AH, Hogg CR, Holder GE (2001) The incidence of negative ERG in clinical practice. Doc Ophthalmol 102:19–30PubMedCrossRef Koh AH, Hogg CR, Holder GE (2001) The incidence of negative ERG in clinical practice. Doc Ophthalmol 102:19–30PubMedCrossRef
8.
go back to reference Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262–266PubMed Lei B, Bush RA, Milam AH, Sieving PA (2000) Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 41:262–266PubMed
9.
go back to reference Alexander KA, Barnes CS, Fishman GA, Milam AH (2002) Nature of the cone on- pathway dysfunction in melanoma associated retinopathy. Invest Ophthalmol Vis Sc 43(4):1189–1197 Alexander KA, Barnes CS, Fishman GA, Milam AH (2002) Nature of the cone on- pathway dysfunction in melanoma associated retinopathy. Invest Ophthalmol Vis Sc 43(4):1189–1197
10.
go back to reference Goetgebuer G, Kestelyn-Stevens AM, De Laey JJ, Kestelyn P, Leroy BP (2008) Cancer-associated retinopathy (CAR) with electronegative ERG: a case report. Doc Ophthalmol 116:49–55PubMedCrossRef Goetgebuer G, Kestelyn-Stevens AM, De Laey JJ, Kestelyn P, Leroy BP (2008) Cancer-associated retinopathy (CAR) with electronegative ERG: a case report. Doc Ophthalmol 116:49–55PubMedCrossRef
11.
go back to reference Kim SJ, Toma HS, Thirkill CE, Dunn JP (2010) Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer. Ocul Immunol Inflamm 18(2):107–109PubMedCrossRef Kim SJ, Toma HS, Thirkill CE, Dunn JP (2010) Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer. Ocul Immunol Inflamm 18(2):107–109PubMedCrossRef
12.
go back to reference Ing EB, Younge BR, Leavitt JA, Lee RA, Bostwick DG (1995) Paraneoplastic retinopathy and gynecologic malignancy. J Pelvic Surg 1:79–83 Ing EB, Younge BR, Leavitt JA, Lee RA, Bostwick DG (1995) Paraneoplastic retinopathy and gynecologic malignancy. J Pelvic Surg 1:79–83
13.
go back to reference Rizzo JF, Gittinger JW (1992) Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology 99:1286–1295PubMed Rizzo JF, Gittinger JW (1992) Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology 99:1286–1295PubMed
14.
go back to reference Cao R, Cao Y (2010) Cancer-associated retinopathy: a new mechanism insight on vascular remodeling. Cell Cycle 9(10):1882–1885PubMedCrossRef Cao R, Cao Y (2010) Cancer-associated retinopathy: a new mechanism insight on vascular remodeling. Cell Cycle 9(10):1882–1885PubMedCrossRef
Metadata
Title
Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction
Authors
Anastasios Anastasakis
Andrew D. Dick
Erika M. Damato
Paul G. Spry
Mohamed A. Majid
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Documenta Ophthalmologica / Issue 1/2011
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-011-9277-y

Other articles of this Issue 1/2011

Documenta Ophthalmologica 1/2011 Go to the issue